MedPath

Markers of Appetite Regulation During Exogenous Ketosis

Not Applicable
Conditions
Ketosis
Interventions
Dietary Supplement: Tap water
Dietary Supplement: Glucose
Dietary Supplement: Ketone ester
Registration Number
NCT04156477
Lead Sponsor
Central Jutland Regional Hospital
Brief Summary

The aim of this study is to investigate the relationship, if any, between markers of satiety, desire to eat, hunger, and metabolic markers of the regulation hereof during ketosis as compared with a Glucose-containing and a Placebo drink adjusted for taste.

Detailed Description

All subjects are, in random order, tested on three separate occasions with intake of weight adjusted and taste matched drink of i) a ketone ester, and ii) an isocaloric and -volumetric glucose drink, or iii) an isovolumetric tap water drink.

Subjects are studied for five hours with baseline and blood sampling on multiple occasions. A satiety questionaire are included.

Subjects are recruited through notice on website for this purpose. Sample size calculations were performed prior to inclusion (n=10). According to protocolized statistical plan, missing data will not be replaced and no imputation will occur. Data will be analyzed by applying a repeated measurements multilevel model with intervention, time and their interactions as categorical factors. Effects size are adjusted for small sample size.

Recruitment & Eligibility

Status
UNKNOWN
Sex
Male
Target Recruitment
10
Inclusion Criteria
  • Males aged 18-65 years
  • BMI 20-35 kg/m2
  • Expected ease of catheter insertion
  • Oral and written informed consent
Exclusion Criteria
  • Inability to fully understand the consent including consent forms
  • Inability to cooperate to the trial
  • Any electrolyte disorders, kidney disease or otherwise compromised renal function including excess risk hereof, e.g. hypertension, albuminuria, autoimmune disease, family history of kidney disease
  • Any liver or bile disease including excess risk hereof, e.g. hepatotoxic drugs, alcohol abuse disorder, gallstones, pancreatitis, autoimmune disease, family history of liver disease
  • Diabetes mellitus or any metabolic and/or hormonal disease including diagnosed/undiagnosed reactive hypoglycemia or similar disorders. This includes treatment with drugs, dietary supplement with inference on key metabolic or hormonal markers, e.g. insulin, glukagon, lipids, and GLP-1
  • Any use of illegal or otherwise use of medicinal products without prescription
  • Anemia or other know disease of the hematopoietic system
  • Previous bariatric surgery
  • Previous myocardial infarction or uncontrolled myocardial ischemia
  • Recent intended/unintended weight loss
  • Allergies to catheters or adhesives

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Isovolumetric tap water drinkTap waterIntake of a taste matched tap water drink.
Isocaloric and -volumetric glucose drinkGlucoseIntake of a taste matched glucogenic drink.
Ketone esterKetone esterIntake of a ketogenic drink.
Primary Outcome Measures
NameTimeMethod
GLP-1 concentration5 hours

Development of GLP-1 concentration during ketosis as compared after intake of a ketogenic vs a glucogenic drink vs a control drink, respectively.

Acyl ghrelin concentration5 hours

Development of acyl ghrelin concentration during ketosis as compared after intake of a ketogenic vs a glucogenic drink vs a control drink, respectively.

Secondary Outcome Measures
NameTimeMethod
Satiety, desire to eat, and perceived hunger sensation5 hours

Scores of satiety, desire to eat, and perceived hunger sensation during intervention all measured on a scale from 1-100 where 1 is the lowest score and 100 the highest.

Insulin concentration5 hours

Development of insulin concentration during ketosis as compared after intake of a ketogenic vs a glucogenic drink vs a control drink, respectively.

Glucose concentration5 hours

Development of glucose concentration during ketosis as compared after intake of a ketogenic vs a glucogenic drink vs a control drink, respectively.

Free fatty acids concentration5 hours

Development of free fatty acids concentration during ketosis as compared after intake of a ketogenic vs a glucogenic drink vs a control drink, respectively.

Trial Locations

Locations (1)

Regionshospitalet Viborg

🇩🇰

Viborg, Denmark

© Copyright 2025. All Rights Reserved by MedPath